LabCorp

LabCorp

Signal active

Investment Firm

Overview

Labcorp specializes in providing physicians with laboratory tests. They develop new tests that provide enhanced accuracy and additional clinical information. Their customers include physicians and their patients, hospitals and managed care plans, private employers, military and law enforcement agencies, and pharmaceutical and biotechnology companies.

Highlights

Founded

1978

Industry

Biotechnology

Employees

10001+

Investment

44

Lead Investment

9

Exits

5

Stages

Early Stage Venture, Late Stage Venture, Seed

Investor Type

N/A

Location

United States, North America

Contact Information

Social

Profile Resume

LabCorp, established in 1978 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Seed investments across Cloud Computing, Biotechnology, Health Care, Personal Health, Hospital, Health Diagnostics, Electronic Health Record (EHR), Financial Services, Venture Capital, Finance. The organization boasts a portfolio of 44 investments, with an average round size of $28.8M and 5 successful exits. Their recent investments include Flatiron Health, Google Ventures, Andreessen Horowitz, Social Capital, First Round Capital. The highest investment round they participated in was $99.5B. Among their most notable exits are Flatiron Health and Google Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Christopher S. Drescher

Christopher S. Drescher

Head of Biopharm Commercial Oncology

imagePlace Adam H. Schechter

Adam H. Schechter

Chairman and CEO

imagePlace Peter M. Neupert

Peter M. Neupert

Lead Independent Director and Board Member

imagePlace Lance V. Berberian

Lance V. Berberian

EVP / Chief Information and Technology Officer

imagePlace Kerrii B. Anderson

Kerrii B. Anderson

Board of Director

imagePlace Robert E. Mittelstaedt, Jr.

Robert E. Mittelstaedt, Jr.

Board of Director

Investment portfolio

LabCorp has made 44 investments. Their most recent investment was on May 06, 2024, when Phenomix Sciences raised $5.5M.

LabCorp has made 17 diversity investments. Their most recent diversity investment was on May 07, 2024, when Acclinate raised $7.0M.

investments

44

Diversity investments

17

Lead investments

9

Number of exits

5

Investments

44

Annouced DateOrganization NameIndustryMoney Raised
Oct 24, 2023
HealthEC HealthEC
Information Technologynull
Apr 01, 2024
Xcell Biosciences Xcell Biosciences
Biotechnologynull
May 06, 2024
Phenomix Sciences Phenomix Sciences
Biotechnology5.5M
May 07, 2024
Acclinate Acclinate
Health Care7.0M

Exits

5

Funding Timeline

Funding rounds

44

Investors

0

Funds

0

Funding Rounds

44

LabCorp has raised 44 rounds. Their latest funding was raised on May 07, 2024 from a Series A - Acclinate round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Oct 24, 2023
Venture Round - HealthEC Venture Round - HealthEC
-0-
Apr 01, 2024
Corporate Round - Xcell Biosciences Corporate Round - Xcell Biosciences
-0-
May 06, 2024
Series A - Phenomix Sciences Series A - Phenomix Sciences
-5.5M-
May 07, 2024
Series A - Acclinate Series A - Acclinate
-7.0M-

Investors

1

Investor NameLead InvestorFunding RoundMoney Raised
-No
Post-IPO Debt - LabCorp
850.0M

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.